Form 4 for PCVX Vaxcyte, Inc.
Accepted 2023-11-28 00:00:00 ET · period of report 2023-11-24 · accession 0001209191-23-056818 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-11-28 | 2023-11-24 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale | $49.09 | -15.0K | 370.9K | -4% | -$736.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-24 | S | D | 11,221 | $48.96 | 374,693 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $48.345 to $49.33. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-11-24 | S | D | 3,779 | $49.46 | 370,914 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $49.35 to $49.89. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |